Project Grant R01DK149282
- Federal Project Grant Award Summary Dr. San Diego at Scripps Health received a $165,541 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, through July 31, 2030. The award supports a career development initiative (K01) that integrates continuous glucose monitoring (CGM) technology into diabetes self-management education and...
- Summary of Federal Project Grant Award The University of Michigan received a $769,155 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), with an award date of September 12, 2025, and completion date of July 31, 2030. The grant funds the Michigan Diabetes Project, a research initiative designed to develop and evaluate a virtually administered,...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the Regents of the University of Michigan a $779,978 Project Grant on September 6, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative addresses critical health disparities in diabetes management by developing and testing adaptive intervention sequences designed to improve outcomes for individuals with...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the Regents of the University of Michigan a $780,220 Project Grant on February 27, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and optimize a scalable digital behavioral intervention for reducing Level 2 hypoglycemia in adults with Type 1 Diabetes (T1D). The project, which will conclude by January 31, 2030,...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases awarded a $784,276 Project Grant to the University of Houston System on July 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports the "Supporting Monitoring and Remote Tracking for Prediabetes (SMART Prediabetes)" initiative, a five-year research project extending through June 30, 2031. The project delivers a...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases awarded Johns Hopkins University a Project Grant of $819,091 on September 11, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research titled "Glucose Patterns and Clinical Outcomes in the Dallas Heart Study: A Pathway to Precision Diabetes." The grant extends through June 30, 2030, and funds a comprehensive investigation using...
- Federal Grant Award Summary Award Overview Albert Einstein College of Medicine received a $827,240 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective June 1, 2026, with an ultimate completion date of March 31, 2031. The award supports T2D-CATCH (Type 2 Diabetes-Collaboration Around Technology Using Community Health Workers), a 12-month randomized...
- Federal Project Grant Award Summary Integrated Medical Sensors Inc. received a $569,998 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025 through July 31, 2026. The award funds the development and validation of optimized data processing algorithms for real-time glucose monitoring on the company's proprietary multi-sensor...
- Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Project Grant totaling $799,752 to The Research Foundation for the State University of New York (effective July 1, 2026, through June 30, 2031) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant funds a clinical research study comparing the efficacy of continuous glucose monitoring (CGM) relative to traditional finger-stick self-monitoring of...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Scripps Research Institute a $801,662 Project Grant effective August 15, 2025, through June 30, 2029, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project investigates the initiation of anti-islet autoimmunity in Type 1 Diabetes (T1D), a CD4 T cell-mediated autoimmune disease, with particular focus on understanding the role...
Scripps Health received a $574,932 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective July 1, 2026 through June 30, 2031. The award funds development and evaluation of the EDGE (Enhancing DULCE Digital with CGM-Driven Personalization, Peer Support, Gamification, and Engagement) intervention, a digital health platform designed to improve Type 2 Diabetes (T2D) self-management in non-insulin-using adults. The intervention integrates continuous glucose monitoring (CGM)-driven personalized messaging, virtual peer health coaching, and gamification elements to address engagement and real-time glycemic feedback gaps in existing digital diabetes management tools. The project delivers research services through two primary aims: Aim 1 conducts a randomized controlled trial with 262 participants to assess EDGE's effectiveness in improving clinical outcomes (HbA1c levels, CGM metrics, and medication dosage) and patient-reported outcomes (diabetes distress, self-care behaviors, and quality of life) compared to DULCE Digital alone, with data collection at baseline, 6 months, and 12 months; Aim 2 evaluates implementation feasibility within primary care settings to support scalability and adoption of the intervention.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $574.9k | 7/1/26 |